"Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients

Fertility and Sterility

Volumn 69, Issue 3 SUPPL. 2, 1998, Pages 454-460

  Tortoriello, Drew V ^a   McGovern, Peter G ^a   Colón, José M ^a   Skurnick, Joan H ^a   Lipetz, Kenneth ^a   Santoro, Nanette ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Coasting; In vitro fertilization; Ovarian hyperstimulation syndrome

Indexed keywords

ESTRADIOL; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; UROFOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; OVARY FOLLICLE; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; LEUPROLIDE; LOGISTIC MODELS; MALE; MICROINJECTIONS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 0031892962     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(97)00560-8     Document Type: Article

References (24)

1. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margoliath EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1988;159:210-5.
2. Kemmann E, Tavakoli F, Shelden RM, Jones JR. Induction of ovulation with menotropins in women with polycystic ovary syndrome. Am J Obstet Gynecol 1981;141:58-64.
3. MacDougall MJ, Tan SJ, Jacobs HS. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992;7:597-600.
4. McClure N, Leya J, Radwanska E, Rawlins R, Haning RV. Luteal phase support and severe ovarian hyperstimulation syndrome. Hum Reprod 1992;7:758-64.
5. Haning RV, Strawn EY, Nolten WE. Pathophysiology of the ovarian hyperstimulation syndrome. Obstet Gynecol 1985;66:220-4.
6. Shalev E, Giladi Y, Matilsky M, Ben-Ami M. Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilisation patients receiving intravenous albumin: a prospective study. Hum Reprod 1995;10:1373-6.
7. Amit A, Yaron Y, Yovel I, Peyser MR, David MP, Botchan A, Lessing JB. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders. Hum Reprod 1993;8:1184-6.
8. Tiitinen A, Husa LM, Tulppala M, Simberg N, Seppala M. The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995;102:326-9.
9. Awonuga AO, Pittrof RJ, Zaidi J, Dean N, Jacobs HS, Tan SL. Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate. J Assist Reprod Genet 1996;13:401-6.
10. Urman B, Pride SM, Yuen BH. Management of overstimulated gonadotropin cycles with a controlled drift period. Hum Reprod 1992;7:213-7.
11. Ben-Nun I, Shulman A, Ghetler Y, Shilon M, Kaneti H, Beyth Y. The significance of 17β-estradiol levels in highly responding women during ovulation induction in IVF treatment: impact and prognostic value with respect to oocyte maturation and treatment outcome. J Assist Reprod Genet 1993;10:213-5.
12. Sher G, Zouves C, Feinman M, Maassarani G. "Prolonged coasting": an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 1995;10:3107-9.
13. Benadiva CA, Davis O, Kligman I, Moomjy M, Liu HC, Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 1997;67:724-7.
14. Adams J, Poison DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986;293:355-9.
15. Golan A, Ron-El R, Herman A, Soffer Y, Weinraab Z, Caspi E. Ovarian hyperstimulation: an update review. Obstet Gynecol Surv 1989;6:430-40.
16. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.
17. Dahl Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994;9:792-9.
18. Gratton RJ, Nisker JA, Daniel S, Toth S, Gunter J, Kaplan BR, et al. An aggressive philosophy in controlled ovarian stimulation cycles increases pregnancy rates. Hum Reprod 1993;8:528-31.
19. Gidley-Baird AA, O'Neill C, Sinosich MJ, Porter RN, Pike IL, Saunders DM. Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progesterone/estrogen ratios in humans and mice. Fertil Steril 1986;54:69-74.
20. Chun SY, Eisenhauer KM, Minami S, Billig H, Perlas E, Hsueh AJW. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinol 1996;137:1447-56.
21. Morris RS, Wong IL, Kirkman E, Gentschein E, Paulson RJ. Inhibition of ovarian derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation. Hum Reprod 1995;10:1355-8.
22. McClure N, Healy DL, Rogers PAW, Sullivan J, Beaton L, Haning RV, et al. Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235-6.
23. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80:1967-71.
24. Christenson LK, Stouffer RL. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J Clin Endocrinol Metab 1997;82:2135-4.